SMid Cap Biotech Analyst Cheng holds a conference call with President & CEO Protopapas, CFO & SVP DeSchuytner and CMO & SVP Yang on May 3 at 11 am hosted by JPMorgan.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MRSN:
- JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
- Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- J.P. Morgan Suggests 2 Stocks to Buy, Including One With 140% Upside Potential
- Mersana Therapeutics upgraded to Overweight from Neutral at JPMorgan
- Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial